Agency Forms Undergoing Paperwork Reduction Act Review, 69086 [2010-28337]
Download as PDF
69086
Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices
organization or other affiliation, full
address and phone, fax, and e-mail
information or e-mail this information
to FindYouthInfo@air.org. Additional
identification documents may be
required.
Dated: November 4, 2010.
Sherry Glied,
Assistant Secretary for Planning and
Evaluation.
Authority: Division F, Pub. L. 111–8; E.O.
13459, 73 FR 8003, February 12, 2008.
[FR Doc. 2010–28396 Filed 11–9–10; 8:45 am]
BILLING CODE 4154–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–10–10DE]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC), Agency for Toxic
Substances and Disease Registry
(ATSDR) publishes a list of information
collection requests under review by the
Office of management and Budget
(OMB) in compliance with the
Paperwork Reduction Act (33 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer, at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to ATSDR Desk Officer,
Office of Management and Budget,
Washington, DC 20503 or by fax to (202)
395–5806. Written comments should be
received within 30 days of this notice.
Proposed Project
Creation of State and Metropolitan
Area-based Surveillance Projects for
Amyotrophic Lateral Sclerosis (ALS)—
New—Agency for Toxic Substances and
Disease Registry (ATSDR).
Background and Brief Description
On October 10, 2008, President Bush
signed S. 1382: ALS Registry Act which
amended the Public Health Service Act
to provide for the establishment of an
Amyotrophic Lateral Sclerosis (ALS)
Registry. The activities described are
part of the effort to create the National
ALS Registry. The purpose of the
registry is to: (1) Better describe the
incidence and prevalence of ALS in the
United States; (2) examine appropriate
factors, such as environmental and
occupational, that might be associated
with the disease; (3) better outline key
demographic factors (such as age, race
or ethnicity, gender, and family history
of individuals diagnosed with the
disease); and (4) better examine the
connection between ALS and other
motor neuron disorders that can be
confused with ALS, misdiagnosed as
ALS, and in some cases progress to ALS.
The registry will collect personal health
information that may provide a basis for
further scientific studies of potential
risks for developing ALS.
This project purposes to collect
information-specific data related to
ALS. The objective of this project is to
develop state-based and metropolitan
area-based surveillance projects for
ALS. The primary goal of the state-based
and metropolitan area-based
surveillance project is to use these data
to evaluate the completeness of the
National ALS Registry. The secondary
goal of the surveillance project is to
obtain reliable and timely information
on the incidence and prevalence of ALS
and to better describe the demographic
characteristics (e.g., age, race, sex, and
geographic location) of those with ALS.
Neurologists or their staff will
complete an ALS Case Reporting Form
on each of their ALS patients. This will
be transmitted to the state or
metropolitan health department. The
contract surveillance staff assigned to
the state and metropolitan area health
departments will train medical
personnel how to complete the ALS
Case Reporting Form (Attachment 3)
and assist with abstracting records as
requested. An ALS Medical Record
Verification Form will be collected on a
subset of cases reported. Each medical
provider reporting source should keep a
line listing of individuals diagnosed
with or thought to have ALS along with
information on whether or not the case
was reported and if not, the reason.
Surveillance items to be collected
include information to make sure that
there are no duplicates. There are no
costs to the respondents other than their
time. The estimated annualized burden
hours are 703.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of data collection instrument
Type of respondent
Training ...........................................................
ALS Case Reporting Form .............................
ALS Medical Record Verification Form ..........
Line Listing (record keeping) ..........................
Medical Personnel/Neurologist ......................
Medical Personnel/Neurologist ......................
Neurologist .....................................................
Medical Personnel ..........................................
Dated: November 4, 2010.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention/Agency for
Toxic Substances and Disease Registry.
emcdonald on DSK2BSOYB1PROD with NOTICES
[FR Doc. 2010–28337 Filed 11–9–10; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB review; comment
request; NCCAM Office of
Communications and Public Liaison
Communications Program Planning
and Evaluation Research
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Center for Complementary and
Alternative Medicine (NCCAM), the
SUMMARY:
VerDate Mar<15>2010
18:25 Nov 09, 2010
Jkt 223001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
243
2,250
450
243
Number of
responses per
respondent
1
1
1
1
Average
burden per
response
(in hours)
30/60
5/60
20/60
1
National Institutes of Health (NIH), has
submitted to the Office of Management
and Budget (OMB) a request to review
and approve the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on August 25, 2010
(Vol. 75, No. 164, p. 52349) and allowed
60-days for public comment. There was
one public comments received during
this time. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
E:\FR\FM\10NON1.SGM
10NON1
Agencies
[Federal Register Volume 75, Number 217 (Wednesday, November 10, 2010)]
[Notices]
[Page 69086]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-10-10DE]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC), Agency for
Toxic Substances and Disease Registry (ATSDR) publishes a list of
information collection requests under review by the Office of
management and Budget (OMB) in compliance with the Paperwork Reduction
Act (33 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer, at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to ATSDR Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
Creation of State and Metropolitan Area-based Surveillance Projects
for Amyotrophic Lateral Sclerosis (ALS)--New--Agency for Toxic
Substances and Disease Registry (ATSDR).
Background and Brief Description
On October 10, 2008, President Bush signed S. 1382: ALS Registry
Act which amended the Public Health Service Act to provide for the
establishment of an Amyotrophic Lateral Sclerosis (ALS) Registry. The
activities described are part of the effort to create the National ALS
Registry. The purpose of the registry is to: (1) Better describe the
incidence and prevalence of ALS in the United States; (2) examine
appropriate factors, such as environmental and occupational, that might
be associated with the disease; (3) better outline key demographic
factors (such as age, race or ethnicity, gender, and family history of
individuals diagnosed with the disease); and (4) better examine the
connection between ALS and other motor neuron disorders that can be
confused with ALS, misdiagnosed as ALS, and in some cases progress to
ALS. The registry will collect personal health information that may
provide a basis for further scientific studies of potential risks for
developing ALS.
This project purposes to collect information-specific data related
to ALS. The objective of this project is to develop state-based and
metropolitan area-based surveillance projects for ALS. The primary goal
of the state-based and metropolitan area-based surveillance project is
to use these data to evaluate the completeness of the National ALS
Registry. The secondary goal of the surveillance project is to obtain
reliable and timely information on the incidence and prevalence of ALS
and to better describe the demographic characteristics (e.g., age,
race, sex, and geographic location) of those with ALS.
Neurologists or their staff will complete an ALS Case Reporting
Form on each of their ALS patients. This will be transmitted to the
state or metropolitan health department. The contract surveillance
staff assigned to the state and metropolitan area health departments
will train medical personnel how to complete the ALS Case Reporting
Form (Attachment 3) and assist with abstracting records as requested.
An ALS Medical Record Verification Form will be collected on a subset
of cases reported. Each medical provider reporting source should keep a
line listing of individuals diagnosed with or thought to have ALS along
with information on whether or not the case was reported and if not,
the reason. Surveillance items to be collected include information to
make sure that there are no duplicates. There are no costs to the
respondents other than their time. The estimated annualized burden
hours are 703.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of data collection instrument Type of respondent respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Training.............................. Medical Personnel/ 243 1 30/60
Neurologist.
ALS Case Reporting Form............... Medical Personnel/ 2,250 1 5/60
Neurologist.
ALS Medical Record Verification Form.. Neurologist............. 450 1 20/60
Line Listing (record keeping)......... Medical Personnel....... 243 1 1
----------------------------------------------------------------------------------------------------------------
Dated: November 4, 2010.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention/Agency for Toxic Substances and Disease Registry.
[FR Doc. 2010-28337 Filed 11-9-10; 8:45 am]
BILLING CODE P